Search PubMed⌕ Search

Biomedical subjects

K Gyr

Publications and source records attributed to K Gyr.

At least 181 records · Page 10Linked to original sources
PubMed1982

[Endoscopic papillotomy].

In the period 1977 to 1982, 145 endoscopic papillotomies have been attempted at the University Hospital, Basel. The procedure was successful in 112 patients or 77%. Endoscopic papillotomy was performed for the following two main indications: choledocholithiasis (118 patients; 81%), suspicion of papillary stenosis (22 patients; 15%). Complications occurred in 8 patients (5.5%) with subsequent surgery in only one case and no death. The data are compared with those in the literature.

Adult↗
PubMed1982

[Diarrhea caused by parasites].

The role of parasites as etiologic agents in diarrhea is emphasized. In countries of western Europe, Entamoeba histolytica and Giardia lamblia are the most prevalent species, although some other 20 protozoans and helminths may lead to diarrheic disturbances. Parasitology, pathogenesis, clinical signs, diagnosis and therapy are briefly outlined. The need for competence on the part of the personnel responsible for laboratory diagnosis is emphasized; also, newly developed immunodiagnostic methods may render appreciable services in doubtful cases. Adequate therapy yields successful results in over 90% of patients.

Amebiasis↗
PubMed1982

Comparative effects of synthetic and natural secretin on pancreatic secretion and on secretin, insulin, and glucagon levels in man.

The effect of synthetic secretin (Roche) on exocrine pancreatic secretion and on secretin, insulin, and glucagon levels was determined and compared with that of pure natural porcine secretin (GIH, Karolinska Institutet, Stockholm) in 10 healthy volunteers. The two secretin preparations were found to be equipotent. Equipotency applies to pancreatic secretion and to secretin and insulin plasma levels, whereas the plasma levels of glucagon were not affected by either drug. It is concluded that this synthetic secretin preparation is suitable for clinical and research purposes.

Adult↗
PubMed1982

Effect of adding albumin to solutions of cholecystokinin on pancreatic protein output and pancreatic polypeptide release.

In four conscious dogs with chronic gastric and pancreatic Thomas fistulas we studied the effect of 99% pure cholecystokinin-33 (CCK-33) solutions on pancreatic secretion and PP release. CCK-33 was dissolved in 0.154 M NaCl alone or in the same solution containing 1 g per 100 ml dog albumin. The response of pancreatic protein output to increasing doses of CCK-33 (0.5, 1, 2, 4 IDU/kg per h) was significantly (P less than 0.05) higher when CCK was dissolved in NaCl with albumin than in NaCl alone. These results were confirmed by measuring CCK immunoreactivity in samples from tips of infusion lines by a gastrin radioimmunoassay. Release of pancreatic polypeptide (PP) following increasing doses of CCK-33 was also significantly (P less than 0.05) elevated when CCK was dissolved in an albumin-containing solution. There was a significant (P less than 0.02) correlation between plasma concentrations of PP and pancreatic protein output. This study suggests that albumin should be added to CCK-33 solutions to preserve biological activity. The biological effect of CCK-33 may be substantially underestimated if albumin is omitted.

Animals↗
PubMed1981

[Ratio of amylase clearance and creatinine clearance in the diagnosis of acute pancreatitis].

In 21 healthy volunteers the ratio of amylase clearance and creatinine clearance (Cam/Ccr) was determined in urine collected at admission, after a 1-hour collection period and after a 2-hour collection period. The normal values were 1.8 +/- 1.6%, 1.9 +/- 2% and 2.0 +/- 1.7% respectively. They were comparable with those published by others. The reproducibility of the method was acceptable (r = 0.62). When compared with serum amylase determinations, Cam/Ccr showed neither better sensitivity in 19 patients suffering an acute episode of proven pancreatitis, nor better specificity in 19 patients with acute abdomen but no evidence of pancreatitis.

Acute Disease↗
PubMed1981

[Release of pancreatic polypeptide induced by cholecystokinin in man and dog].

In four healthy volunteers increasing doses of intravenous CCK-33 induced an increase in plasma PP concentration measured by RIA. PP concentration rose from a basal level of 67 +/- 15 pmol/l to 198 +/- 45 pmol/l with 2 IDU/kg/h (p less than 0.05). In four mongrel dogs equipped with Thomas cannulas, the same doses induced a more pronounced rise in plasma PP (p less than 0.01). It is concluded that intravenous CCK-33 induces the release of PP in man and dog in a dose-dependent manner.

Animals↗
PubMed1981

[Diagnosis of intestinal amebiasis].

Three cases of intestinal amebiasis with varying clinical pictures are presented. One patient developed an amebic liver abscess and also amebic colitis, which was mistaken for Crohn's disease. A second patient with amebic dysentery had no Entamoeba histolytica trophozoites in fecal material because of previous therapy with an antiprotozoal drug. The third patient, who had colitis and severe constitutional symptoms, had trophozoites in the stool but negative serological tests. The diagnostic value of radiology and endoscopy, of examinations of stool and exsudate, and of histopathology and serology is discussed.

Acetanilides↗
PubMed1981

Assessment of exocrine pancreatic function by oral administration of N-benzoyl-L-tyrosyl-p-aminobenzoic acid (Bentiromide): 5 years' clinical experience.

Exocrine pancreatic function was assessed in 588 subjects by oral administration of 1 g of the chymotrypsin-labile peptide N-benzoyl-L-tyrosyl-p-aminobenzoic acid (Bentiromide) from 1974 to 1979. The pancreatic function test (PFT) was performed in 126 controls, 217 patients with pancreatic diseases, 196 patients with various non-pancreatic gastrointestinal disease, 18 patients with renal disease and 31 patients with various other diagnoses. In 62 of 72 patients (86 per cent) with chronic pancreatitis and in 19 of 25 (76 per cent) with pancreatic carcinoma, the excretion of p-aminobenzoic acid (PABA) in the urine was significantly less than in the controls. In contrast, 328 of 353 controls and patients with non-pancreatic diseases (93 per cent) had PABA excretion within normal limits. The sensitivity and specificity of the Bentiromide-test observed in this study is sufficient to detect moderate to severe disturbances of pancreatic exocrine function. The PFT has proved to be an easy and reliable screening test for pancreatic exocrine function in ambulatory as well as in hospitalized patients.

4-Aminobenzoic Acid↗
PubMed1981

The release of pancreatic polypeptide by exogenous CCK in man and dog.

4 healthy volunteers received commercial 20% pure CCK-33 in 4 consecutive doses of 0.5, 1.0, 2.0, 4.0 IDU/kg/h. blood samples were assayed for pancreatic polypeptide (PP) by radioimmunoassay. Plasma PP concentrations increased stepwise from a basal level of 67 +/- 15 pmol/l to a maximum of 198 +/- 46 pmol/l (p less than 0.05). In 4 mongrel dogs with Thomas cannulas, the same doses of 99% pure CCK-33 were successively infused. Plasma PP concentrations rose stepwise with each dose from 44 +/- 7 to 259 +/- 43 pmol/l (p less than 0.02). This rise significantly correlated with pancreatic protein secretion (p less than 0.01). It is concluded that intravenous CCK-33 induces the release of PP in man and in dog, in a dose-dependent manner.

Animals↗
PubMed1981

Response of small intestinal flora to elemental diet and pancreatic duct ligation in vervet monkey.

The small intestinal flora of vervet monkeys (cercopithecus aethiops) was examined before and after feeding elemental diet and after ligation of the pancreatic duct. Elemental diet did not produce significant changes of the intestinal microbial flora. However, an increase of the microbial count consisting mainly of Enterobacteriaceae, molds and yeasts was observed in the duct-ligated animals, significantly more pronounced than in the sham-operated controls. The data confirm previous studies demonstrating the possible role of the exocrine pancreas in the maintenance of a normal intestinal flora.

Animals↗
PubMed1981

Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects.

The effect of somatostatin on splanchnic hemodynamics was determined in 8 patients with cirrhosis of the liver and in 18 normal subjects using arterial-hepatic-venous catheterization. Estimated hepatic blood flow determined by indocyanine green infusion was 1.36 +/- 0.23 L/min (+/- SEM) in patients with cirrhosis and remained unaffected during 30 min of somatostatin (250 microgram/h) administration. Wedged hepatic venous pressure which was elevated to 23 +/- 1.8 mmHg was also uninfluenced. In contrast to somatostatin, an infusion of vasopressin (12 U/h for 30 min) given to the same patients, lowered estimated blood flow by 28% (p < 0.05) and wedged hepatic venous pressure by 18% (p < 0.02). Arterial gastrin and insulin levels were lowered during somatostatin infusion by 33% (p < 0.02) and by 75% (p < 0.005), respectively. In contrast to the cirrhosis, infusion of 250 microgram/h somatostatin into normal subjects was associated with a decrease of estimated hepatic blood flow from 1.20 +/- 0.16 to 0.88 +/- 0.12 L/min (p < 0.01) representing a 27% decline. Arterial gastrin and insulin concentrations were lower (p < 0.01) than in cirrhosis, but the basal levels were lowered by somatostatin to a similar degree in both groups of patients. A higher dose of somatostatin (500 microgram/h) administered to normal subjects resulted in a similar decrease of gastrin and of estimated hepatic blood flow as that seen with 250 microgram/h, whereas a lower dose (125 microgram/h) decreased gastrin but failed to influence estimated hepatic blood flow. Thus, somatostatin at a dose which has been used in the treatment of acute peptic ulcer hemorrhage (250 microgram/h) failed to influence estimated hepatic blood flow and wegded hepatic venous pressure in patients with cirrhosis but lowered splanchnic blood flow in normal subjects. Assuming that this effect contributes to somatostatin's therapeutic efficacy, these results cast doubt on its potential value in the treatment of upper gastrointestinal bleeding of cirrhotics with portal hypertension.

Dose-Response Relationship, Drug↗